Hospitals can expect to spend 4.57% more on drugs in 2020
(By Alia Paavola for Becker’s Hospital Review) Including inpatient and outpatient environments, hospitals and health systems can expect a 4.57
Read More
2020 election brewing ‘perfect storm’ for drug-pricing reform, analyst says
(By Alia Paavola for Becker’s Hospital Review) With President Donald Trump and Democrats both seeking healthcare policy wins ahead of
Read MoreFinancial Performance of Medicare Advantage, Individual, and Group Health Insurance Markets
(By Gretchen Jacobson, Rachel Fehr, Cynthia Cox, and Tricia Neuman for Kaiser Family Foundation) Medicare-for-All proposals have sparked discussion about
Read MoreAmid rising concern, pay-to-play clinical trials are drawing federal scrutiny
(By Rebecca Robbins for STAT) Michele Russell-Einhorn has spent 23 years working in the world of institutional review boards, which
Read MoreInsured Americans increasingly turning to charity to pay for healthcare: 5 takeaways
(By Kelly Gooch for Becker’s Hospital Review) Insured Americans are relying more on charity to pay for healthcare due to
Read MoreTrump Wants To Take Guns Away From People In Crisis. Will That Work?
(By Liz Szabo for Kaiser Health News) In his response Monday to mass shootings in El Paso, Texas, and Dayton,
Read MoreChanges coming that would help some rural and other hospitals in their labor markets
The Centers for Medicare and Medicaid Services has made public policy changes that will increase the wage index for certain
Read MorePreventing pneumonia is easy
(Source: www.medicare.gov/blog) Did you know that about 1 million Americans go to the hospital with pneumonia every year? Pneumonia is
Read MoreSuperstar Athletes Popularize Unproven Stem Cell Procedures
(By Liz Szabo for Kaiser Health News) Baseball superstar Max Scherzer — whose back injury has prevented him from pitching for
Read MoreDrugmakers Now ‘Masters’ At Rolling Out Their Own Generics To Stifle Competition
(By Jay Hancock and Sydney Lupkin for Kaiser Health News) When PDL BioPharma’s $40 million blood-pressure medicine faced the threat
Read More